D

Dicerna Pharmaceuticals Inc
F:DPL

Watchlist Manager
Dicerna Pharmaceuticals Inc
F:DPL
Watchlist
Price: 33.51 EUR Market Closed
Market Cap: 2.6B EUR

Wall Street
Price Targets

DPL Price Targets Summary
Dicerna Pharmaceuticals Inc

There are no price targets for DPL.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Dicerna Pharmaceuticals Inc Competitors:
Price Targets
2616
CStone Pharmaceuticals
160% Upside
300685
Amoy Diagnostics Co Ltd
44% Upside
BIIB
Biogen Inc
4% Upside
LTRN
Lantern Pharma Inc.
498% Upside
OPK
OPKO Health Inc
190% Upside
URGN
Urogen Pharma Ltd
59% Upside
ELDN
Eledon Pharmaceuticals Inc
423% Upside
LXRX
Lexicon Pharmaceuticals Inc
151% Upside

Revenue
Forecast

Revenue Estimate
Dicerna Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Dicerna Pharmaceuticals Inc's revenue is 48%. The projected CAGR for the next 2 years is 8%.

48%
Past Growth
8%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Dicerna Pharmaceuticals Inc

Operating Income forecast
is not available for
Dicerna Pharmaceuticals Inc

Net Income
Forecast

Net Income Estimate
Dicerna Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DPL's stock price target?
Not Available

DPL doesn't have any price targets made by Wall Street professionals.

What is Dicerna Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Dicerna Pharmaceuticals Inc's revenue is 48%. The projected CAGR for the next 2 years is 8%.

Back to Top